Treatment Considerations in KRAS NSCLC

M

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12Cm NSCLC Who Have Untreated CNS Metastases

By Marcelo Negrao 2 Videos
473 views
July 21, 2023
Comments 0
Login to view comments. Click here to Login
04:42

NSCLC Panel Discussion: Should a Patient With High PD-L1 Wait for Ge…

GRACE

K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar

285 views
06:29

WCLC 2023 Insights: "KRYSTAL-1 - Two-Year Follow-Up of Adagrasib Mon…

Insights from 2023 WCLC

S. Gadgeel

174 views
21:16

Targeted Therapies in Lung Cancer 2023: Translating Cancer Discovery…

GRACE

J. Sabari

150 views
14:45

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity,…

Yale Cancer Center

A. Nassar

219 views
17:07

NOS ASCO® 2023 Review: Targeting Advanced KRAS and EGFR Mutations in…

Nebraska Oncology Society

V. Lam

102 views
18:14

Understanding KRAS G12C Positive Lung Cancer

Janakiraman Subramanian

658 views
09:17

The Data on Novel KRAS G12C Inhibitors: Focus on Adagrasib

Shirish Gadgeel

342 views
33:14

Direct KRAS Inhibition in NSCLC: Past, Present, and Future

Benjamin Herzberg

250 views